
    
      Methods :

      One hundred patients with a metastatic prostate cancer will be recruited plus 50 healthy
      donors. Twenty ml of blood will be drawn : 10 ml of blood will be drawn on CellSave tubes
      (fixed cells) for CTC detection using the FDA-cleared CellSearch system (gold standard) and
      10 ml of blood will be drawn on EDTA tubes (viable cells) for the detection of functional
      CTCs using the EPIDROP. Patients will be followed for 18 months.

      Samples from fifty control subjects will be provided by the Etablissement Fran√ßais du Sang.
    
  